Vertex Pharmaceuticals | VRTX - PE价格收益



金融业
股票价格
USD 508.99
资产
USD 27.42B
现金及等价物
USD 7.85B
销售成本
USD 489.2M
流动资产
USD 12.54B
流动负债
USD 3.94B
债务
USD 1.98B
EBIT
USD 1.27B
EBITDA
USD 1.33B
员工
6.1K
EPS每股收益
USD 4.73
股本和储备
USD 20.25B
销售毛利
USD 2.84B
债务利息支出
USD 3.3M
利息收入
USD 120.6M
贷款资金
USD 106.7M
市值
USD 131.68B
净收入
USD 1.1B
营业费用
USD 2.07B
营业利润
USD 1.27B
普通股股本
USD 253.3M
PE价格收益
28.05
税前利润
USD 1.39B
销售收入
USD 3.33B
销售和管理费用
USD 582.2M
股票
USD 1.77B
贸易债权人
USD 3.61B
应收帐款人
USD 2.13B


Pe 更改 日
AbbVie 23.96 0.93 2026-06
Acadia Pharmaceuticals 11.33 1.25 2026-06
Agios Pharmaceuticals 3.56 0 2026-03
Alnylam Pharmaceuticals 75.64 4.4 2026-06
Amgen 18.07 1.77 2026-06
Arrowhead Research 39.19 0 2026-06
Biogen 23.23 9.53 2026-06
BioMarin Pharmaceutical 21.07 5.79 2026-06
Bristol-Myers Squibb 16.14 7.06 2026-06
Gilead Sciences 13.51 4.2 2026-06
Incyte 14.45 0.9 2026-06
Ionis Pharmaceuticals 396.15 79.28 2022-09
J&J 25.86 3.57 2026-09
Merck 32.26 15.74 2026-06
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 22.1 5.99 2026-06
Novartis 22.41 2.24 2026-06
Pfizer 11.48 2.16 2026-06
PTC Therapeutics 8.76 1.22 2026-03
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Roche Holding 16.48 0.39 2026-06
Sanofi 18.96 7.12 2026-06
Sarepta Therapeutics 27.27 0 2026-03
United Therapeutics 19.15 1.27 2026-06
Vertex Pharmaceuticals 28.05 2.22 2026-06